Effects of fish oil on some parameters of fibrinolysis and lipoprotein(a) in healthy subjects.
Haglund
O
O
Department of Forensic Medicine, University of Uppsala, Sweden.
Mehta
J L
JL
Saldeen
T
T
D000328:Adult; D000941:Antigens / Q000097:blood; D004281:Docosahexaenoic Acids / Q000627:therapeutic use; D004311:Double-Blind Method; D015118:Eicosapentaenoic Acid / Q000627:therapeutic use; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use*; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis / Q000187:drug effects*; D005395:Fish Oils / Q000627:therapeutic use*; D006801:Humans; D017270:Lipoprotein(a) / Q000097:blood*; D008297:Male; D008875:Middle Aged; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood / Q000276:immunology; D010959:Tissue Plasminogen Activator / Q000276:immunology; D014280:Triglycerides / Q000097:blood; D014810:Vitamin E / Q000627:therapeutic use
D000941:Antigens; D015525:Fatty Acids, Omega-3; D005395:Fish Oils; D017270:Lipoprotein(a); D017395:Plasminogen Activator Inhibitor 1; D014280:Triglycerides; D014810:Vitamin E; D004281:Docosahexaenoic Acids; D005340:Fibrinogen; D015118:Eicosapentaenoic Acid; D010959:Tissue Plasminogen Activator